Offer - Urjas Oil for just ₹ 1 X
Olmesar M 50 Tablet ER is a prescription drug, available for use as Tablet. The alternative uses of Olmesar M 50 Tablet ER have also been explained below.
The correct dosage of Olmesar M 50 Tablet ER depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Olmesar M 50 Tablet ER include Upper respiratory tract infection, Slow heart rate (pulse). Some other side effects of Olmesar M 50 Tablet ER have been listed ahead. Usually, these side effects of Olmesar M 50 Tablet ER go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Olmesar M 50 Tablet ER has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, Olmesar M 50 Tablet ER's effects on the liver, heart and kidney are discussed below in the Olmesar M 50 Tablet ER related warnings section.
Olmesar M 50 Tablet ER is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Bradycardia (Slow Heart Rate) as it can result in adverse effects. Other contraindications of Olmesar M 50 Tablet ER have been discussed in the sections ahead.
Besides this, Olmesar M 50 Tablet ER may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Olmesar M 50 Tablet ER, it is important to know that it is not safe while driving, and is not habit-forming.
Olmesar M 50 Tablet ER is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesar M 50 Tablet ER safe for pregnant women?
Pregnant women may get severe side effects after taking Olmesar M. If you are pregnant, do not take Olmesar M without a doctor's advice.
Is the use of Olmesar M 50 Tablet ER safe during breastfeeding?
Olmesar M has been seen to have minimal side effects on breastfeeding women.
What is the effect of Olmesar M 50 Tablet ER on the Kidneys?
Olmesar M does not damage the kidneys.
What is the effect of Olmesar M 50 Tablet ER on the Liver?
Very few cases of side effects of Olmesar M on the liver have been reported.
What is the effect of Olmesar M 50 Tablet ER on the Heart?
Very few cases of side effects of Olmesar M on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Olmesar M 50 Tablet ER unless your doctor advises you to do so -
Is this Olmesar M 50 Tablet ER habit forming or addictive?
No, there is no any evidence that Olmesar M 50 Tablet ER is addictive.
Interaction between Food and Olmesar M 50 Tablet ER
Olmesar M 50 Tablet ER may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Olmesar M 50 Tablet ER
Consuming Olmesar M 50 Tablet ER with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850